JUANOLGAR 3 mg LOZENGES EUCALYPTUS FLAVORED

2. What you need to know before taking Juanolgar

Do not take Juanolgar

• If you are allergic to bencidamine or to any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before taking Juanolgar

• If you suffer from phenylketonuria.
• If you have had or have asthma.
• If you are allergic to acetylsalicylic acid or other anti-inflammatory analgesics (NSAIDs).
• If your doctor has told you that you have intolerance to some sugars, contact your doctor before taking this medication.
• If the pain in the mouth or throat worsens or persists for more than 3 days, fever appears or other symptoms, and since in a limited number of patients, buco-pharyngeal ulcers can be a sign of serious pathologies, consult your doctor or dentist.

Taking Juanolgar with other medications

Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medication.

Taking Juanolgar with food and beverages

Food and beverages do not affect the taking of this medication.

Pregnancy and lactation

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medication.

Juanolgar should not be taken during pregnancy.

Juanolgar should not be taken during breastfeeding.

Driving and using machines

The use of Juanolgar does not affect the ability to drive or use machines.

Juanolgar contains:

Isomalt: if your doctor has indicated that you have intolerance to certain sugars, consult with him before taking this medication.

Eucalyptus oil with d-limonene: may cause allergic reactions.

3. How to take Juanolgar

Follow exactly the administration instructions of the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

Adults and children over 6 years of age: 1 lozenge 3 times a day. Do not take more than 3 lozenges in 24 hours.

Use in children

Children from 6 to 11 years old: this medication should always be administered under the supervision of an adult.

The pharmaceutical form of lozenges should not be given to children under 6 years of age.

Juanolgar cannot be taken for more than 7 days.

How to take:

Buco-pharyngeal use.

Let a lozenge dissolve slowly in the mouth.

Do not swallow.

Do not chew.

If you take more Juanolgar than you should

If you accidentally take too many lozenges, contact your pharmacist, doctor, or the emergency service of the nearest hospital immediately. Always carry the medication package with you, whether or not there are lozenges left.

Although it can occur very rarely, the symptoms of overdose reported in children are excitement, convulsions, sweating, alterations in gait, tremors, and vomiting after oral administration of doses about 100 times higher than those of 1 lozenge.

If you have more questions about the use of this product, consult your doctor or pharmacist.

In case of overdose or accidental ingestion of large quantities of Juanolgar, go immediately to a medical center or call the Toxicology Information Service, phone: 915.620.420, indicating the medication and the amount ingested.

4. Possible side effects

Like all medications, this medication can cause side effects, although not all people experience them.

Uncommon (may affect up to 1 in 100 people):

• Skin sensitivity to sunlight (causing rash or sunburn).

Rare (may affect up to 1 in 1,000 people):

• Feeling of burning or dryness of the mouth. If this happens to you, try drinking a glass of water to reduce the effect.

Very rare (may affect up to 1 in 10,000 people):

• Sudden swelling of the mouth/throat and mucous membranes (angioedema).
• Difficulty breathing (laryngospasm).

Unknown (frequency cannot be estimated from available data):

• Local loss of oral mucosa sensitivity (oral hypoesthesia).
• Allergic reaction (hypersensitivity)
• Severe allergic reaction (anaphylactic reactions), whose signs may include difficulty breathing, pain or pressure in the chest and/or feeling of dizziness/fainting, intense itching of the skin or bumps on the skin, swelling of the face, lips, tongue, and/or throat, and which can be potentially fatal.

Reporting of side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Juanolgar

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date that appears on the package after the abbreviation CAD. The expiration date is the last day of the month indicated.

Do not store at a temperature above 30°C.

Keep in the original packaging to protect it from moisture.

Medications should not be thrown down the drain or into the trash. Deposit the packages and medications you no longer need at the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This way, you will help protect the environment.

6. Contents of the package and additional information

Composition of Juanolgar

• The active ingredient is bencidamine hydrochloride.
• Each lozenge contains 3 mg of bencidamine hydrochloride (equivalent to 2.68 mg of bencidamine).
• The other components (excipients) are: isomalt (E953), acesulfame potassium, citric acid monohydrate, eucalyptus essential oil, levomenthol, quinoline yellow (E 104), indigotine (E132).

Appearance of the product and contents of the package

This medication is presented as dark green square lozenges with a central cavity.

The lozenges can be packaged in PVC/PE/PVDC-ALU blister packs or wrapped in paraffin paper.

Package with 20 or 30 lozenges.

Only some package sizes may be marketed.

Marketing authorization holder

ANGELINI PHARMA ESPAÑA, S.L.

c/ Antonio Machado, 78-80

3rd floor, module A-Australia Building

08840 Viladecans, Barcelona (Spain)

Manufacturer

A.C.R.A.F. S.p.A.,

Via Vecchia del Pinocchio, 22

60131 – Ancona, Italy

This medication is authorized in the Member States of the European Economic Area under the following names:

Italy:Tantum Verde P, 3mg pastiglie gusto eucalipto

Spain:Juanolgar 3 mg Lozenges with eucalyptus flavor

Denmark:Zyx eucalyptus 3mg sugetabletter

Sweden: Zyx Eucalyptus 3 mg sugtabletter

United Kingdom:Difflam 3 mg Lozenges, eucalyptus flavor

This package leaflet was approved in August 2023.

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/